Skip to main content

Want a detailed portfolio tracker?

Performance analysis of Aprea Therapeutics (APRE)

Annual Return

Over the past 3 years, APRE has had an average annual return of -41.33%, underperforming the benchmark SPY, which returned +19.63% annual.

Over the past 5 years, APRE has had an average annual return of -62.40%, underperforming the benchmark SPY, which returned +12.73% annual.

Since Oct 3, 2019, APRE has had an average annual return of -61.18%, underperforming the benchmark SPY, which returned +16.60% annual.

20262025202420232022202120202019
-23.81%-73.75%-30.43%-28.57%-88.50%-41.67%-89.28%+123.85%

Monthly Return

YearJanFebMarAprMayJunJulAugSepOctNovDecAnnually Total
2026-9.52%+15.79%-13.64%+5.26%+10%-9.09%-20.00%-23.81%
2025+18.75%-34.74%-19.35%-16.00%+0%-2.38%+0%-7.32%-5.26%-5.56%-8.82%-32.26%-73.75%
2024+9.57%+63.49%-20.87%-23.93%-6.45%-14.66%-11.11%-4.55%-20.24%+41.79%-25.26%+12.68%-30.43%
2023+52.17%-48.98%-13.60%-10.19%-3.09%-18.09%-1.30%+18.42%+13.33%-19.61%+8.54%+29.21%-28.57%
2022-27.14%-16.76%+6.83%-21.50%-42.56%-10.51%+27.87%-17.31%-18.09%+3.15%-38.23%-20.30%-88.50%
2021+12.21%+9.21%-15.40%-8.04%-10.01%+15.59%-13.32%+9.26%+10.60%-3.13%-18.39%-28.97%-41.67%
2020-16.45%-10.53%+1.34%-8.55%-15.51%+44.38%-29.27%-1.20%-11.22%-9.36%+15.73%-80.51%-89.28%
2019+17.80%+4.27%+82.24%+123.85%

Drawdown analysis of Aprea Therapeutics (APRE)

The maximum drawdown for the APRE was -99.94%, occurring on Jan 29, 2026. This drawdown has not yet recovered.

The current APRE drawdown is -99.93%.

Since Oct 3, 2019 APRE has experienced the following drawdowns:

  • 50% or more: 1 time
  • 40% or more: 1 time
  • 30% or more: 1 time
  • 20% or more: 2 times
  • 10% or more: 3 times
DepthStartTo BottomBottomTo RecoverEndTotal
-99.94%Dec 27, 20191529Jan 29, 2026OngoingOngoingOngoing
-24.77%Nov 19, 20195Nov 26, 20199Dec 10, 201914
-17.45%Dec 12, 20194Dec 18, 20194Dec 24, 20198
-8.93%Oct 21, 20197Oct 30, 201911Nov 14, 201918
-7.61%Oct 3, 20193Oct 8, 20198Oct 18, 201911
-0.91%Nov 15, 20191Nov 18, 20191Nov 19, 20192